Catalyst Wire Dossier Catalyst Wire Dossier

Drop 0.4%

0.4% ophthalmic solution · Avizor SA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Drop 0.4%, covering 2025-07-09 to 2025-07-09. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial for the Evaluation of Safety and Efficacy of Drop 0.4% [Phase 3]

See pricing